our solutions
We are driven by the unwavering belief that
“knowing more about the magnitude of risks can lead to smarter drug development as well as smarter investments” – Alan Eisenberg
The DDRN Concept: Embracing the Multi-Dimensional and Interconnected Nature of Risk in Drug Development.
1
DDRNAi
Drug Development Risk Network (DDRNAI)
- Model and predict the probability of clinical trial success using advanced AI approaches.
- Optimize clinical trial design parameters to enhance scientific validity and operational effectiveness.
- Streamline clinical trial execution workflows to improve trial efficiency and outcome reliability.
- Perform multidimensional risk assessments to proactively anticipate and mitigate potential trial-related challenges.
De-risk pipeline investments by identifying potential challenges early and modeling their impact on clinical and commercial success probabilities.
2
PPMAi
Pharmaceutical Portfolio Management (PPMAI)
- Prioritize pipeline assets
- Streamline portfolio strategy to enhance R&D decision-making.
- Added incremental value to the due diligence and scenario assessment process.
- Make more informed choices in risk-evaluation around clinical development funding or potential external acquisition initiatives.